These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7908850)

  • 21. Lack of effect of chronic morphine treatment and naloxone-precipitated withdrawal on tyrosine hydroxylase, galanin, and neuropeptide Y mRNA levels in the rat locus coeruleus.
    Holmes PV; de Bartolomeis A; Koprivica V; Crawley JN
    Synapse; 1995 Mar; 19(3):197-205. PubMed ID: 7540319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of acute and chronic opioid withdrawal by a selective soluble guanylyl cyclase inhibitor.
    Sullivan ME; Hall SR; Milne B; Jhamandas K
    Brain Res; 2000 Mar; 859(1):45-56. PubMed ID: 10720614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of the locus coeruleus and N-methyl-D-aspartic acid (NMDA) and AMPA receptors in opiate withdrawal.
    Rasmussen K
    Neuropsychopharmacology; 1995 Dec; 13(4):295-300. PubMed ID: 8747753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A selective AMPA antagonist, LY293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal.
    Rasmussen K; Kendrick WT; Kogan JH; Aghajanian GK
    Neuropsychopharmacology; 1996 Nov; 15(5):497-505. PubMed ID: 8914123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of glutamatergic systems in locus coeruleus to nucleus paragigantocellularis stimulation-evoked behavior.
    Liu N; Ho IK; Rockhold RW
    Pharmacol Biochem Behav; 1999 Aug; 63(4):555-67. PubMed ID: 10462184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local opiate withdrawal in locus coeruleus in vivo.
    Aston-Jones G; Hirata H; Akaoka H
    Brain Res; 1997 Aug; 765(2):331-6. PubMed ID: 9313908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antagonism of orexin type 1 receptors in the locus coeruleus attenuates signs of naloxone-precipitated morphine withdrawal in rats.
    Azizi H; Mirnajafi-Zadeh J; Rohampour K; Semnanian S
    Neurosci Lett; 2010 Oct; 482(3):255-9. PubMed ID: 20667500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of naloxone-precipitated morphine withdrawal on noradrenaline release in rat hippocampus in vivo.
    Done C; Silverstone P; Sharp T
    Eur J Pharmacol; 1992 May; 215(2-3):333-6. PubMed ID: 1397000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Local opiate withdrawal in locus coeruleus neurons in vitro.
    Ivanov A; Aston-Jones G
    J Neurophysiol; 2001 Jun; 85(6):2388-97. PubMed ID: 11387385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The selective mGlu2/3 receptor agonist LY354740 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal.
    Vandergriff J; Rasmussen K
    Neuropharmacology; 1999 Feb; 38(2):217-22. PubMed ID: 10218862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extraneuronal noradrenaline in the prefrontal cortex of morphine-dependent rats: tolerance and withdrawal mechanisms.
    Rossetti ZL; Longu G; Mercuro G; Gessa GL
    Brain Res; 1993 Apr; 609(1-2):316-20. PubMed ID: 8508313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal.
    Caillé S; Espejo EF; Reneric JP; Cador M; Koob GF; Stinus L
    J Pharmacol Exp Ther; 1999 Aug; 290(2):881-92. PubMed ID: 10411605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morphine withdrawal increases expression of GABA(A) receptor epsilon subunit mRNA in locus coeruleus neurons.
    Heikkilä AT; Echenko O; Uusi-Oukari M; Sinkkonen ST; Korpi ER
    Neuroreport; 2001 Sep; 12(13):2981-5. PubMed ID: 11588615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mGlu5 receptor antagonists MPEP and MTEP attenuate behavioral signs of morphine withdrawal and morphine-withdrawal-induced activation of locus coeruleus neurons in rats.
    Rasmussen K; Martin H; Berger JE; Seager MA
    Neuropharmacology; 2005 Feb; 48(2):173-80. PubMed ID: 15695156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitric oxide synthase inhibitors attenuate acute and chronic morphine withdrawal response in the rat locus coeruleus: an in vivo voltammetric study.
    Hall S; Milne B; Jhamandas K
    Brain Res; 1996 Nov; 739(1-2):182-91. PubMed ID: 8955938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonidine but not nifedipine prevents the release of noradrenaline during naloxone-precipitated opiate withdrawal: an in vivo microdialysis study in the rat.
    Silverstone PH; Done C; Sharp T
    Psychopharmacology (Berl); 1992; 109(1-2):235-8. PubMed ID: 1365663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intra-LC microinjection of orexin type-1 receptor antagonist SB-334867 attenuates the expression of glutamate-induced opiate withdrawal like signs during the active phase in rats.
    Hooshmand B; Azizi H; Javan M; Semnanian S
    Neurosci Lett; 2017 Jan; 636():276-281. PubMed ID: 27816550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increase of extracellular dopamine in the medial prefrontal cortex during spontaneous and naloxone-precipitated opiate abstinence.
    Bassareo V; Tanda G; Di Chiara G
    Psychopharmacology (Berl); 1995 Nov; 122(2):202-5. PubMed ID: 8848538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein kinases in the locus coeruleus and periaqueductal gray matter are involved in the expression of opiate withdrawal.
    Maldonado R; Valverde O; Garbay C; Roques BP
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):565-75. PubMed ID: 8751087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic morphine treatment and withdrawal increase extracellular levels of norepinephrine in the rat bed nucleus of the stria terminalis.
    Fuentealba JA; Forray MI; Gysling K
    J Neurochem; 2000 Aug; 75(2):741-8. PubMed ID: 10899950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.